Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict adjuvant chemosensitivity in pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) patients are frequently treated by chemotherapy. Even if personalized therapy based on molecular analysis can be performed for some tumors, PDAC regimens selection is still mainly based on patients' performance status and expected efficacy. Therefore, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicolle, R., Gayet, O., Bigonnet, M., Roques, J., Chanez, B., Puleo, F., Augustin, J., Emile, J.F., Svrcek, M., Arsenijevic, T., Hammel, P., Rebours, V., Giovannini, M., Grandval, P., Dahan, L., Moutardier, V., Mitry, E., Van Laethem, J.L., Bachet, J.B., Cros, J., Iovanna, J., Dusetti, N.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8681024/
https://www.ncbi.nlm.nih.gov/pubmed/34906890
http://dx.doi.org/10.1016/j.tranon.2021.101315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8681024/
https://www.ncbi.nlm.nih.gov/pubmed/34906890
http://dx.doi.org/10.1016/j.tranon.2021.101315

Ejemplares similares